trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

There is an effective cure for Ebola

the verdict
SUPPORTED
the evidence backs this
Recorded sources
4 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that there is an effective cure for Ebola?

Yes. Clinical trials and regulatory approvals confirm that specific monoclonal antibody treatments, such as REGN-EB3 and mAb114, are effective in treating Ebola virus disease and significantly reducing mortality.

Verdict: SUPPORTED · 4 sources for, 0 against · Last checked

The analysis

The retrieved literature contains multiple high-quality sources, including randomized controlled trials and systematic reviews, demonstrating that targeted monoclonal antibody treatments (such as Ansuvimab, mAb114, and REGN-EB3) are effective therapies that significantly reduce mortality in Ebola virus disease. There are no papers refuting the existence of effective treatments.

Evidence for · 4
Monoclonal Antibody Approved to Treat Ebola
2021
Ansuvimab-zykl (Ebanga) is an approved human monoclonal antibody used to treat Zaire ebolavirus infection.
Get citation
Aschenbrenner, D. S. (2021). Monoclonal Antibody Approved to Treat Ebola. doi.org. https://doi.org/10.1097/01.naj.0000742484.81331.b2

See more details
More for · 3
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.
2019
A randomized controlled trial demonstrated that monoclonal antibody therapies such as MAb114 and REGN-EB3 are effective in reducing mortality from Ebola virus disease.
Get citation
Mulangu, S., Dodd, L. E., Davey, R. T., Mbaya, O. T., Proschan, M., Mukadi, D., Manzo, M. L., Nzolo, D., Oloma, A. T., Ibanda, A., Ali, R., Coulibaly, S., Levine, A. C., Grais, R., Diaz, J., Lane, H. C., Muyembe-Tamfum, J., Sivahera, B., Camara, M., Kojan, R., Walker, R., Dighero-Kemp, B., Cao, H., Mukumbayi, P., Mbala-Kingebeni, P., Ahuka, S., Albert, S., Bonnett, T., Crozier, I., Duvenhage, M., Proffitt, C., Teitelbaum, M., Moench, T., Aboulhab, J., Barrett, K., Cahill, K., Cone, K., Eckes, R., Hensley, L., Herpin, B., Higgs, E., Ledgerwood, J., Pierson, J., Smolskis, M., Sow, Y., Tierney, J., Sivapalasingam, S., Holman, W., Gettinger, N., Vallée, D., & Nordwall, J. (2019). A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.. doi.org. https://doi.org/10.1056/NEJMoa1910993

Effects of therapies for Ebola virus disease: a systematic review and network meta-analysis.
2022
A systematic review and network meta-analysis confirmed that treatments like REGN-EB3 and mAb114 significantly reduce mortality in patients with Ebola virus disease compared to standard care.
Get citation
Gao, Y., Zhao, Y., Guyatt, G., Fowler, R., Kojan, R., Ge, L., Tian, J., & Hao, Q. (2022). Effects of therapies for Ebola virus disease: a systematic review and network meta-analysis.. doi.org. https://doi.org/10.1016/S2666-5247(22)00123-9

Viral hemorrhagic fevers - therapeutic trial advances and challenges.
2025
Recent therapeutic advancements include monoclonal antibodies for Ebola virus disease that have demonstrated clinical efficacy.
Get citation
Güllü, D., Keske, Ş., & Ergönül, Ö. (2025). Viral hemorrhagic fevers - therapeutic trial advances and challenges.. doi.org. https://doi.org/10.1080/14787210.2025.2592294

Related receipts

What does the evidence say?

The retrieved literature contains multiple high-quality sources, including randomized controlled trials and systematic reviews, demonstrating that targeted monoclonal antibody treatments (such as Ansuvimab, mAb114, and REGN-EB3) are effective therapies that significantly reduce mortality in Ebola virus disease. There are no papers refuting the existence of effective treatments.

Receipt History
first checked31 Jul 2026
judged → SUPPORTED · 7931 Jul 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work